Matches in Wikidata for { <http://www.wikidata.org/entity/Q79365801> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- Q79365801 description "artículu científicu espublizáu en payares de 2006" @default.
- Q79365801 description "im November 2006 veröffentlichter wissenschaftlicher Artikel" @default.
- Q79365801 description "scientific article published on 01 November 2006" @default.
- Q79365801 description "wetenschappelijk artikel" @default.
- Q79365801 description "наукова стаття, опублікована в листопаді 2006" @default.
- Q79365801 name "Chronomodulated irinotecan, oxaliplatin, and leucovorin-modulated 5-Fluorouracil as ambulatory salvage therapy in patients with irinotecan- and oxaliplatin-resistant metastatic colorectal cancer" @default.
- Q79365801 name "Chronomodulated irinotecan, oxaliplatin, and leucovorin-modulated 5-Fluorouracil as ambulatory salvage therapy in patients with irinotecan- and oxaliplatin-resistant metastatic colorectal cancer" @default.
- Q79365801 type Item @default.
- Q79365801 label "Chronomodulated irinotecan, oxaliplatin, and leucovorin-modulated 5-Fluorouracil as ambulatory salvage therapy in patients with irinotecan- and oxaliplatin-resistant metastatic colorectal cancer" @default.
- Q79365801 label "Chronomodulated irinotecan, oxaliplatin, and leucovorin-modulated 5-Fluorouracil as ambulatory salvage therapy in patients with irinotecan- and oxaliplatin-resistant metastatic colorectal cancer" @default.
- Q79365801 prefLabel "Chronomodulated irinotecan, oxaliplatin, and leucovorin-modulated 5-Fluorouracil as ambulatory salvage therapy in patients with irinotecan- and oxaliplatin-resistant metastatic colorectal cancer" @default.
- Q79365801 prefLabel "Chronomodulated irinotecan, oxaliplatin, and leucovorin-modulated 5-Fluorouracil as ambulatory salvage therapy in patients with irinotecan- and oxaliplatin-resistant metastatic colorectal cancer" @default.
- Q79365801 P1433 Q79365801-94E41074-54AF-495E-84E1-4897A0A9911D @default.
- Q79365801 P1476 Q79365801-E0B23B11-F2FC-4CDD-B88D-ECC5CCC15EFB @default.
- Q79365801 P2093 Q79365801-11DA713B-F7A8-41B8-8AFF-5AC9420DE7BB @default.
- Q79365801 P2093 Q79365801-5212367B-867A-430A-AAD5-79FC88CC2745 @default.
- Q79365801 P2093 Q79365801-5903845F-4FA9-4A91-A16A-8FDC38F3CE76 @default.
- Q79365801 P2093 Q79365801-6660E6C0-F6D3-4556-9419-E2C4290B94F0 @default.
- Q79365801 P2093 Q79365801-90BC76B2-3320-4597-834E-0E2C5BEF385A @default.
- Q79365801 P2093 Q79365801-91C6D1A1-D7ED-41E8-9107-AFB8257D5F50 @default.
- Q79365801 P2093 Q79365801-A7478915-B1B0-48FB-B14C-DA69C9307A3E @default.
- Q79365801 P2093 Q79365801-B3F0CD4E-ADAC-441A-9AF6-046F3DFB2696 @default.
- Q79365801 P2093 Q79365801-EDA62E36-042B-4AE8-9A0D-A18D315F8174 @default.
- Q79365801 P2093 Q79365801-F082B9BE-AC60-4785-9343-F67C6993354B @default.
- Q79365801 P2093 Q79365801-F6F7601A-1855-40C7-82D9-739D27840449 @default.
- Q79365801 P304 Q79365801-0314AFE7-0CB7-411D-A92A-A5BC7775DDF6 @default.
- Q79365801 P31 Q79365801-A8BF365B-91EC-4636-9694-24248304672F @default.
- Q79365801 P356 Q79365801-467FF1B5-A105-43A1-826D-B66ED8725F94 @default.
- Q79365801 P433 Q79365801-F366DE41-E8D4-470C-8572-59904FCAD135 @default.
- Q79365801 P478 Q79365801-4DDB5BF9-C6B6-432C-9E18-9C420D399DF6 @default.
- Q79365801 P577 Q79365801-1E71D677-5628-415B-9EC1-B49FF894AE18 @default.
- Q79365801 P698 Q79365801-BAE2955E-9516-44C0-85CB-26EF79B0B594 @default.
- Q79365801 P921 Q79365801-00F9FD95-D101-4BD5-A1DC-1C8721968A4F @default.
- Q79365801 P921 Q79365801-0364F925-E918-47E1-9B5F-4335C107BD9B @default.
- Q79365801 P921 Q79365801-9B31285A-84AF-4E49-9080-BB518BAE8EAA @default.
- Q79365801 P921 Q79365801-9B425622-513F-4649-AD56-10B207CB73F1 @default.
- Q79365801 P921 Q79365801-C0B9D7C0-30D9-4D7A-8C01-5EA83DB7EAE3 @default.
- Q79365801 P921 Q79365801-DC8AB473-8014-4377-BBCA-F0BB084EBD42 @default.
- Q79365801 P356 THEONCOLOGIST.11-10-1072 @default.
- Q79365801 P698 17110626 @default.
- Q79365801 P1433 Q2122327 @default.
- Q79365801 P1476 "Chronomodulated irinotecan, oxaliplatin, and leucovorin-modulated 5-Fluorouracil as ambulatory salvage therapy in patients with irinotecan- and oxaliplatin-resistant metastatic colorectal cancer" @default.
- Q79365801 P2093 "Béatrice Ducot" @default.
- Q79365801 P2093 "Catherine Brézault-Bonnet" @default.
- Q79365801 P2093 "Claude Jasmin" @default.
- Q79365801 P2093 "Dany Gholam" @default.
- Q79365801 P2093 "Dominique Hauteville" @default.
- Q79365801 P2093 "Francis Kustlinger" @default.
- Q79365801 P2093 "Francis Lévi" @default.
- Q79365801 P2093 "Mohamed Bouchahda" @default.
- Q79365801 P2093 "Odile Ghémard" @default.
- Q79365801 P2093 "René Adam" @default.
- Q79365801 P2093 "Sylvie Giacchetti" @default.
- Q79365801 P304 "1072-1080" @default.
- Q79365801 P31 Q13442814 @default.
- Q79365801 P356 "10.1634/THEONCOLOGIST.11-10-1072" @default.
- Q79365801 P433 "10" @default.
- Q79365801 P478 "11" @default.
- Q79365801 P577 "2006-11-01T00:00:00Z" @default.
- Q79365801 P698 "17110626" @default.
- Q79365801 P921 Q108566365 @default.
- Q79365801 P921 Q188874 @default.
- Q79365801 P921 Q238512 @default.
- Q79365801 P921 Q25493920 @default.
- Q79365801 P921 Q412197 @default.
- Q79365801 P921 Q422327 @default.